← Back to Search

Behavioral Intervention

Provider Training for Eating Disorders (OPTED Trial)

N/A

Waitlist Available

Led By Erin C Accurso, PhD

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12-month follow-up

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing two ways of training clinicians in a family-based approach to treating restrictive eating disorders.

Who is the study for?

This trial is for licensed mental health providers in California who treat patients with Medicaid and work in a participating county. Unlicensed providers can join if they have a licensed supervisor. It's not open to students or learners.

What is being tested?

The study compares two training methods for treating restrictive eating disorders: web-based training versus live, in-person training. Mental health clinicians will be randomly assigned to one of these methods.

What are the potential side effects?

Since this trial involves professional training rather than medical treatments, traditional side effects are not applicable. However, participants may experience differences in learning effectiveness or satisfaction.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12-month follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12-month follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Family-Based Treatment Knowledge Assessment (FBT-KA) Score at Post-Training

Number of participants who complete training

Secondary study objectives

Number of participants who receive FBT consultation at 12 months

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Web-based trainingExperimental Treatment1 Intervention

Web-based training will provide online training primarily focused on family-based treatment and appropriate adaptations to the treatment model.

Group II: Live trainingActive Control1 Intervention

Live training will include two days of expert-led live training (via zoom). The content of the training will be similar to that provided in web-based training, primarily focused on family-based treatment and appropriate adaptations to the treatment model.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Web-based training

2022

N/A

~90

Do I qualify?Apply below to find out